An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and peripheral artery disease (PAD), potentially adding yet another ...

Protein this, low-calorie that—but what about fiber supplements? With health and wellness trends at the forefront of ...

Key Finding 1: Stick With 1 Set of Weight Loss Tactics Whatever tactic people chose to lose weight, survey respondents who did so successfully were more than twice as likely to have remained ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials.

After losing 6st within a year of taking the weight-loss drug, one mother-of-three says she plans to stay on it for the rest of her life ...

AT CLOSE 4:00 PM EDT 07/07/25 $ USD AFTER HOURS 7:59 PM EDT 07/07/25 $291.5437 -0.4263 -0.15% AFTER HOURS Vol 463,626 ...